Results of Meeting

Sep 10, 2026 at 10:35 PM EDT · Issued by Radiopharm Theranostics Limited via ASX

Filed with ASX · Sep 10, 2026 at 10:35 PM EDT

On 6ix: 6ix.com/news/results-of-meeting-195

ASX ANNOUNCEMENT 11 September 2026 Radiopharm Theranostics Limited Suite 1, Level 3, 62 Lygon Street, Carlton South VIC 3053 Australia ABN: 57 647 877 889 Results of General Meeting Sydney, Australia – Friday, 11 September 2026 – Radiopharm Theranostics Limited (ASX: RAD; Nasdaq: RADX)...

View Attachment

6ix hasn’t read this filing yet.

Radiopharm Theranostics Limited on 6ix

Earlier from Radiopharm Theranostics

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal AdenocarcinomaSep 9
RAD Announces Positive Data from RAD301 P1 Imaging TrialSep 8
Appendix 4E and Preliminary Final ReportAug 28
Change of Director's Interest Notices x 4Aug 27
Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid TumorsAug 26

Later from Radiopharm Theranostics

RAD oral presentation at SNO26 on RAD101 Phase IIb dataSep 13
Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual MeetingSep 14
Share purchase plan completedSep 16
Application for quotation of securities - RADSep 16
RADOC New Class Options Range of Units and Top 20 HoldersSep 16

All Radiopharm Theranostics news releases

Follow Radiopharm Theranostics into a list and get an email when it puts out news.

Follow Radiopharm Theranostics